9–11 June 2026 | Berlin, Germany
bio:cap is a new international investival bringing together innovators, investors, industry leaders and policymakers from across the life sciences and AI sectors. Hosted in Berlin, one of Europe’s leading innovation hubs, the event aims to accelerate the translation of scientific breakthroughs into market-ready solutions and global impact.
Positioned at the intersection of biotechnology, TechBio, diagnostics and artificial intelligence, bio offers a unique platform for collaboration, investment and strategic dialogue. The event will connect start-ups and scale-ups with venture capital firms, pharmaceutical companies, corporate investors and public decision-makers, creating opportunities to drive innovation and growth across the life sciences ecosystem.
Hosted by Messe Berlin under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), bio combines the energy of a festival with the focus of a high-level industry conference.
What to Expect
- Matchmaking & Partnering – Curated one-to-one meetings connecting innovative companies with investors, corporate partners and potential collaborators.
- Pitch Opportunities – Dedicated stages where start-ups and scale-ups can showcase their innovations and engage directly with investors.
- Inspiring Keynotes – Insights from leading voices in biotechnology, AI, pharmaceuticals, investment and public policy.
- Strategic Networking – Opportunities to connect with global stakeholders across the life sciences value chain.
- Policy & Regulatory Dialogue – Discussions between industry leaders and policymakers on the future frameworks supporting innovation and investment.
Who Should Attend?
- Biotech, TechBio, diagnostics and AI start-ups and scale-ups
- Venture capital and corporate venture capital investors
- Pharmaceutical and healthcare industry leaders
- Innovation agencies and funding organisations
- Policymakers and public sector representatives
- Research organisations and innovation ecosystems
Why Berlin?
As Germany’s leading start-up ecosystem and one of Europe’s largest life sciences clusters, Berlin offers a unique combination of scientific excellence, entrepreneurial talent, investment activity and policymaking influence. The city provides an ideal environment for fostering partnerships, attracting investment and shaping the future of biotechnology and AI-driven healthcare innovation.
bio:cap 2026 aims to become a key meeting point for stakeholders seeking to advance innovation, investment and collaboration across Europe’s life sciences landscape and beyond.



